The global point-of-care diagnostics market size was US$ 29,478.6 million in 2020. The global point-of-care diagnostics market size is estimated to reach US$ 55335.4 million by 2030, growing at a ...

SINGAPORE - Eligible Singapore residents will be able to screen for a genetic condition that causes high cholesterol levels at a subsidised rate as part of a nationwide programme launching on June 30.

It’s not just the cholesterol in your diet that matters when you’re trying to lower your cholesterol levels.

Family reunion at Dr. Richard Holub’s Albany office comes as blood test, medicine for the disease emerge.